We are live on ! Find out more
ICM

IMS Capital Management Portfolio holdings

AUM $217M
1-Year Est. Return 18.69%
This Fund
S&P 500
This Quarter Est. Return
+5.18%
1 Year Est. Return
+18.69%
3 Year Est. Return
+119.31%
5 Year Est. Return
+117.37%
10 Year Est. Return
+287.2%
AUM
$79.5M
AUM Growth
+$7.16M
Cap. Flow
+$3.94M
Cap. Flow %
4.96%
Top 10 Hldgs %
18.72%
Holding
180
New
39
Increased
48
Reduced
37
Closed
31

Top Buys

Rank Stock Value
1
UMPQ
Umpqua Holdings Corp
UMPQ
+$1.16M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$1.13M
3
OPK icon
Opko Health
OPK
+$1.03M
4
JBL icon
Jabil
JBL
+$984K
5
DO
Diamond Offshore Drilling
DO
+$956K

Top Sells

Rank Stock Value
1
SMG icon
ScottsMiracle-Gro
SMG
+$835K
2
KEY icon
KeyCorp
KEY
+$813K
3
SBUX icon
Starbucks
SBUX
+$783K
4
PGH
Pengrowth Energy Corporation
PGH
+$776K
5
FAF icon
First American
FAF
+$765K

Sector Composition

Rank Sector Weight
1 Technology 13.68%
2 Healthcare 12.61%
3 Consumer Discretionary 11.17%
4 Energy 10.55%
5 Financials 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLYG icon
101
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5B
$253K 0.32%
5,660
+120
+2% +$5.13K
EBND icon
102
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.25B
$251K 0.32%
8,444
+571
+7% +$17.2K
SLYV icon
103
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
$251K 0.32%
4,720
+100
+2% +$5.12K
BP icon
104
BP
BP
$112B
$242K 0.3%
6,076
– –
SCCO icon
105
Southern Copper
SCCO
$138B
$241K 0.3%
9,043
+109
+1% +$2.74K
INTC icon
106
Intel
INTC
$413B
$240K 0.3%
9,257
-7,360
-44% -$178K
NVDA icon
107
NVIDIA
NVDA
$4.6T
$240K 0.3%
600,000
– –
RFV icon
108
Invesco S&P MidCap 400 Pure Value ETF
RFV
$336M
$235K 0.3%
+4,631
New +$226K
EEM icon
109
iShares MSCI Emerging Markets ETF
EEM
$27.5B
$230K 0.29%
5,499
-52
-0.9% -$2.18K
SUP
110
DELISTED
Superior Industries International
SUP
$229K 0.29%
11,100
– –
BNS icon
111
Scotiabank
BNS
$105B
$226K 0.28%
3,888
-96
-2% -$5.38K
MAT icon
112
Mattel
MAT
$4.47B
$224K 0.28%
+4,710
New +$210K
BKE icon
113
Buckle
BKE
$2.32B
$223K 0.28%
4,352
– –
GSK icon
114
GSK
GSK
$107B
$222K 0.28%
+3,332
New +$216K
NKE icon
115
Nike
NKE
$64.1B
$219K 0.28%
5,570
-2,950
-35% -$113K
PETS icon
116
PetMed Express
PETS
$42.3M
$219K 0.28%
13,140
– –
WMT icon
117
Walmart Inc
WMT
$909B
$213K 0.27%
8,103
-17,592
-68% -$454K
CHK
118
DELISTED
Chesapeake Energy Corporation
CHK
$212K 0.27%
+41
New +$208K
KRFT
119
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$212K 0.27%
+3,925
New +$210K
TSM icon
120
TSMC
TSM
$1.94T
$211K 0.27%
12,100
– –
UL icon
121
Unilever
UL
$142B
$210K 0.26%
+4,533
New +$203K
VIG icon
122
Vanguard Dividend Appreciation ETF
VIG
$111B
$210K 0.26%
+2,790
New +$203K
SFL icon
123
SFL Corp
SFL
$1.61B
$206K 0.26%
+12,600
New +$206K
VIVO
124
DELISTED
Meridian Bioscience Inc
VIVO
$204K 0.26%
+7,676
New +$189K
TAL
125
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
$204K 0.26%
3,550
-400
-10% -$20.6K
3 4
5
6 7

Similar funds

DSN
D. Scott Neal Lexington, Kentucky $216M AUM 33.28% 1-Year Est. Return
FFAM
Forge First Asset Management Toronto, Ontario, Canada $218M AUM 29.22% 1-Year Est. Return
MS
Marshall & Sullivan Seattle, Washington $216M AUM 12.97% 1-Year Est. Return
NWM
Napa Wealth Management Napa, California $213M AUM 25.01% 1-Year Est. Return
LA
Lindenwold Advisors Reading, Pennsylvania $212M AUM 13.02% 1-Year Est. Return
SNWA
Siligmueller & Norvid Wealth Advisors Glen Ellyn, Illinois $222M AUM 10.94% 1-Year Est. Return
APC
Asset Planning Corporation Knoxville, Tennessee $211M AUM 7.33% 1-Year Est. Return
WTFG
Wells Trecaso Financial Group Akron, Ohio $210M AUM 21.47% 1-Year Est. Return

IMS Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, IMS Capital Management held 180 positions worth $79.5M, up 9.9% from $72.3M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

IMS Capital Management deployed $3.94M of net new capital in Q4 2013, opening 39 new positions and adding to 48 existing holdings. Its largest new stake was Sarepta Therapeutics: 38,000 shares worth $774K.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was ScottsMiracle-Gro, an estimated $835K trimmed.

  • IMS Capital Management's largest Q4 2013 buy was Sarepta Therapeutics: 38,000 shares worth $774K.
  • IMS Capital Management added most to Umpqua Holdings Corp in Q4 2013, an estimated $1.16M increase.
  • IMS Capital Management's biggest Q4 2013 reduction was ScottsMiracle-Gro, cutting an estimated $835K.
  • IMS Capital Management fully exited KeyCorp in Q4 2013, selling an estimated $813K.
  • IMS Capital Management's ten largest holdings make up 19% of its $79.5M portfolio in Q4 2013.
  • IMS Capital Management opened 39 new positions and closed 31 in Q4 2013.
  • IMS Capital Management's portfolio value rose 9.9% quarter-over-quarter to $79.5M.

Based on IMS Capital Management's 13F filing for Q4 2013, filed 5 Feb 2014.